19 Jun 2026
Alembic Pharmaceuticals won USFDA tentative approval for its binimetinib tablet, a drug with US sales of about 260 million dollars.
Tentative approval confirms the filing's quality while final clearance waits on the innovator's patent and exclusivity expiry.